| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Design | 6 | 2019 | 2627 | 0.99 | Why? |
| Receptor, Adenosine A2A | 1 | 2019 | 14 | 0.81 | Why? |
| Naphthyridines | 1 | 2019 | 48 | 0.79 | Why? |
| Hydrazines | 1 | 2019 | 68 | 0.75 | Why? |
| Adenosine | 3 | 2019 | 509 | 0.75 | Why? |
| Hepatocyte Growth Factor | 1 | 2018 | 71 | 0.72 | Why? |
| Artemisinins | 1 | 2020 | 238 | 0.71 | Why? |
| Phenols | 1 | 2019 | 226 | 0.68 | Why? |
| Vascular System Injuries | 1 | 2018 | 91 | 0.68 | Why? |
| Brain Edema | 1 | 2019 | 224 | 0.67 | Why? |
| Enterovirus A, Human | 1 | 2019 | 180 | 0.65 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2019 | 385 | 0.63 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.62 | Why? |
| Colonic Diseases | 1 | 2016 | 96 | 0.58 | Why? |
| Glucosides | 1 | 2019 | 359 | 0.58 | Why? |
| Tumor Microenvironment | 1 | 2017 | 264 | 0.57 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2015 | 113 | 0.55 | Why? |
| Transforming Growth Factor beta | 1 | 2017 | 363 | 0.55 | Why? |
| Intestinal Perforation | 1 | 2016 | 178 | 0.54 | Why? |
| Colectomy | 1 | 2016 | 327 | 0.51 | Why? |
| Proteomics | 2 | 2021 | 2481 | 0.48 | Why? |
| Cerebral Hemorrhage | 1 | 2019 | 820 | 0.45 | Why? |
| Drug Resistance, Neoplasm | 1 | 2015 | 447 | 0.44 | Why? |
| Colon | 1 | 2016 | 669 | 0.44 | Why? |
| Apoptosis | 2 | 2019 | 2335 | 0.44 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.44 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.42 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.41 | Why? |
| Colonoscopy | 1 | 2016 | 738 | 0.41 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.40 | Why? |
| Antiviral Agents | 10 | 2021 | 41703 | 0.38 | Why? |
| Protein Kinase Inhibitors | 1 | 2019 | 1585 | 0.38 | Why? |
| Piperidines | 1 | 2015 | 795 | 0.37 | Why? |
| Drug Repositioning | 4 | 2021 | 5683 | 0.35 | Why? |
| RNA Editing | 2 | 2018 | 80 | 0.34 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.34 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.30 | Why? |
| Molecular Structure | 3 | 2019 | 1539 | 0.30 | Why? |
| Inhibitory Concentration 50 | 3 | 2019 | 907 | 0.29 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.29 | Why? |
| Laparoscopy | 1 | 2016 | 1532 | 0.29 | Why? |
| Structure-Activity Relationship | 3 | 2019 | 2219 | 0.27 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.24 | Why? |
| Amides | 3 | 2020 | 1864 | 0.24 | Why? |
| Oseltamivir | 2 | 2020 | 583 | 0.23 | Why? |
| Solubility | 2 | 2019 | 382 | 0.22 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.21 | Why? |
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2019 | 8 | 0.21 | Why? |
| Cells, Cultured | 4 | 2019 | 5835 | 0.21 | Why? |
| STAT5 Transcription Factor | 1 | 2019 | 34 | 0.20 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 43 | 0.20 | Why? |
| Cyclic AMP | 1 | 2019 | 76 | 0.19 | Why? |
| Pyrazines | 2 | 2020 | 1783 | 0.19 | Why? |
| Transcription Factor RelA | 1 | 2019 | 122 | 0.19 | Why? |
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2019 | 64 | 0.19 | Why? |
| Molecular Docking Simulation | 3 | 2020 | 6902 | 0.19 | Why? |
| Gene Ontology | 1 | 2020 | 391 | 0.19 | Why? |
| Metabolic Networks and Pathways | 1 | 2020 | 285 | 0.19 | Why? |
| Situs Inversus | 1 | 2017 | 14 | 0.18 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 159 | 0.18 | Why? |
| Bile Duct Diseases | 1 | 2017 | 12 | 0.18 | Why? |
| Lithiasis | 1 | 2017 | 15 | 0.18 | Why? |
| Molecular Sequence Annotation | 1 | 2020 | 478 | 0.18 | Why? |
| Tumor Suppressor Proteins | 1 | 2019 | 165 | 0.18 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 159 | 0.18 | Why? |
| Eutheria | 1 | 2020 | 313 | 0.18 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.18 | Why? |
| Gene Expression Regulation | 3 | 2020 | 4020 | 0.17 | Why? |
| Intestinal Absorption | 1 | 2017 | 64 | 0.17 | Why? |
| Phenylurea Compounds | 1 | 2018 | 101 | 0.17 | Why? |
| Antimalarials | 2 | 2020 | 2505 | 0.17 | Why? |
| Receptors, CCR4 | 1 | 2017 | 42 | 0.17 | Why? |
| Immunoconjugates | 1 | 2017 | 90 | 0.17 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2018 | 202 | 0.17 | Why? |
| Drug Discovery | 3 | 2020 | 3092 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Neuroprotective Agents | 1 | 2019 | 240 | 0.16 | Why? |
| Vero Cells | 4 | 2020 | 14117 | 0.16 | Why? |
| Cell Line, Tumor | 5 | 2017 | 3608 | 0.16 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.16 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.15 | Why? |
| Protein Processing, Post-Translational | 1 | 2019 | 634 | 0.15 | Why? |
| Lipopeptides | 1 | 2018 | 229 | 0.15 | Why? |
| Forkhead Transcription Factors | 1 | 2017 | 231 | 0.15 | Why? |
| Valine | 1 | 2017 | 359 | 0.15 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 502 | 0.15 | Why? |
| Animals | 12 | 2020 | 78931 | 0.15 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.15 | Why? |
| CTLA-4 Antigen | 1 | 2017 | 282 | 0.15 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.15 | Why? |
| Receptors, CCR5 | 1 | 2017 | 186 | 0.15 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.14 | Why? |
| Dose-Response Relationship, Drug | 3 | 2019 | 3776 | 0.14 | Why? |
| Alphacoronavirus | 1 | 2020 | 392 | 0.14 | Why? |
| Birds | 1 | 2018 | 412 | 0.14 | Why? |
| Interleukin-2 | 1 | 2017 | 443 | 0.14 | Why? |
| Operative Time | 1 | 2016 | 450 | 0.14 | Why? |
| Rabbits | 1 | 2018 | 1171 | 0.14 | Why? |
| Influenza, Human | 4 | 2020 | 10779 | 0.14 | Why? |
| Viral Fusion Proteins | 1 | 2018 | 399 | 0.14 | Why? |
| Mice, Knockout | 1 | 2019 | 1815 | 0.13 | Why? |
| Ligands | 1 | 2019 | 1300 | 0.13 | Why? |
| Iatrogenic Disease | 1 | 2016 | 304 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.13 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| RNA-Binding Proteins | 2 | 2018 | 1022 | 0.13 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.13 | Why? |
| NF-kappa B | 1 | 2020 | 1301 | 0.13 | Why? |
| Neurons | 1 | 2019 | 864 | 0.13 | Why? |
| Guanidines | 1 | 2017 | 499 | 0.12 | Why? |
| Plants, Medicinal | 1 | 2019 | 622 | 0.12 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.12 | Why? |
| Oxazolone | 1 | 2011 | 4 | 0.12 | Why? |
| HEK293 Cells | 4 | 2019 | 8394 | 0.12 | Why? |
| Nanomedicine | 1 | 2017 | 329 | 0.12 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.12 | Why? |
| Influenza in Birds | 1 | 2018 | 528 | 0.12 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.12 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.12 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.12 | Why? |
| Interleukin-17 | 1 | 2017 | 602 | 0.12 | Why? |
| Computational Biology | 4 | 2021 | 4514 | 0.11 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.11 | Why? |
| Mice, Inbred C57BL | 2 | 2019 | 5542 | 0.11 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.11 | Why? |
| Chemistry, Pharmaceutical | 1 | 2011 | 152 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Small Molecule Libraries | 1 | 2018 | 1060 | 0.10 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.09 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.09 | Why? |
| Signal Transduction | 3 | 2020 | 7207 | 0.09 | Why? |
| Humans | 30 | 2021 | 930598 | 0.09 | Why? |
| Benzamides | 1 | 2011 | 421 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
| Epithelial Cells | 2 | 2018 | 3508 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| Neuraminidase | 1 | 2010 | 289 | 0.09 | Why? |
| Cell Line | 2 | 2020 | 12040 | 0.08 | Why? |
| Binding Sites | 2 | 2020 | 6201 | 0.08 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2010 | 492 | 0.08 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.07 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.07 | Why? |
| Female | 14 | 2021 | 380317 | 0.07 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.07 | Why? |
| Male | 10 | 2020 | 367725 | 0.07 | Why? |
| Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.07 | Why? |
| Models, Chemical | 2 | 2020 | 332 | 0.07 | Why? |
| Molecular Conformation | 2 | 2018 | 374 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Models, Molecular | 2 | 2015 | 7616 | 0.06 | Why? |
| Cell Survival | 2 | 2018 | 1581 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Sepsis | 1 | 2019 | 3517 | 0.06 | Why? |
| Administration, Oral | 2 | 2020 | 2340 | 0.06 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.05 | Why? |
| Sincalide | 1 | 2020 | 10 | 0.05 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Aged | 6 | 2020 | 215776 | 0.05 | Why? |
| Glucosamine | 1 | 2019 | 8 | 0.05 | Why? |
| Nonlinear Dynamics | 1 | 2021 | 177 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Computer Simulation | 1 | 2015 | 4982 | 0.05 | Why? |
| Acetylation | 1 | 2019 | 124 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2019 | 242 | 0.05 | Why? |
| Databases, Pharmaceutical | 1 | 2021 | 345 | 0.05 | Why? |
| Inosine | 1 | 2018 | 9 | 0.05 | Why? |
| Influenzavirus A | 1 | 2018 | 66 | 0.05 | Why? |
| Alu Elements | 1 | 2018 | 22 | 0.05 | Why? |
| Acids, Carbocyclic | 1 | 2017 | 27 | 0.05 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Genetic Markers | 1 | 2019 | 318 | 0.04 | Why? |
| Software | 2 | 2021 | 2501 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2016 | 17020 | 0.04 | Why? |
| Genetic Engineering | 1 | 2020 | 325 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Dynamic Light Scattering | 1 | 2017 | 43 | 0.04 | Why? |
| Polyproteins | 1 | 2020 | 814 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| NIH 3T3 Cells | 1 | 2017 | 147 | 0.04 | Why? |
| Transcriptome | 2 | 2021 | 3466 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.04 | Why? |
| Drug Stability | 1 | 2017 | 236 | 0.04 | Why? |
| Breast Neoplasms | 1 | 2015 | 3633 | 0.04 | Why? |
| Biological Assay | 1 | 2020 | 367 | 0.04 | Why? |
| Permeability | 1 | 2017 | 238 | 0.04 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.04 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2018 | 530 | 0.04 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Hydrodynamics | 1 | 2017 | 177 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Genetic Variation | 2 | 2020 | 3919 | 0.04 | Why? |
| HeLa Cells | 1 | 2019 | 1303 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 2984 | 0.04 | Why? |
| Tissue Distribution | 1 | 2017 | 483 | 0.04 | Why? |
| Immunologic Factors | 1 | 2011 | 4206 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.03 | Why? |
| Doxorubicin | 1 | 2017 | 313 | 0.03 | Why? |
| Incidence | 1 | 2016 | 25622 | 0.03 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.03 | Why? |
| Myeloid Cells | 1 | 2019 | 808 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2017 | 1236 | 0.03 | Why? |
| China | 2 | 2020 | 50654 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2020 | 8843 | 0.03 | Why? |
| Interferon-beta | 1 | 2019 | 979 | 0.03 | Why? |
| Databases, Genetic | 1 | 2019 | 1127 | 0.03 | Why? |
| Down-Regulation | 1 | 2019 | 1416 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2020 | 1074 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Propylene Glycols | 1 | 2011 | 5 | 0.03 | Why? |
| Receptors, Lysosphingolipid | 1 | 2011 | 25 | 0.03 | Why? |
| Polymers | 1 | 2017 | 507 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Protein Interaction Maps | 1 | 2019 | 1333 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.03 | Why? |
| Antineoplastic Agents | 2 | 2017 | 3550 | 0.03 | Why? |
| Adult | 3 | 2021 | 244371 | 0.03 | Why? |
| Sphingosine | 1 | 2011 | 101 | 0.03 | Why? |
| Cricetinae | 1 | 2018 | 3344 | 0.03 | Why? |
| Fingolimod Hydrochloride | 1 | 2011 | 217 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Hydrogen Bonding | 1 | 2011 | 599 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Amino Acids | 1 | 2011 | 552 | 0.02 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.02 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.02 | Why? |
| Transfection | 1 | 2010 | 864 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
| Plasmids | 1 | 2010 | 840 | 0.02 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Virus Internalization | 2 | 2018 | 7921 | 0.02 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2010 | 511 | 0.02 | Why? |
| Mutation | 2 | 2020 | 12376 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Catalytic Domain | 1 | 2011 | 1757 | 0.02 | Why? |
| Retrospective Studies | 1 | 2016 | 105322 | 0.02 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.02 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.02 | Why? |
| Drug Resistance, Viral | 1 | 2010 | 1083 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Enzyme Inhibitors | 1 | 2010 | 1881 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| HIV-1 | 1 | 2010 | 3365 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2011 | 6331 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2019 | 88759 | 0.01 | Why? |